My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
Invest in the best stock opportunities right now and every time.
Start Systematic Stock Investing ...in less than a minute.
US Food and Drug Administration (USFDA) has inspected the Zydus Cadila’s API manufacturing facility located at Ankleshwar in Gujarat. The inspection was conducted from July 22, 2019 to July 26, 2019. This audit covered both Unit I and II. At the end of the inspection, no observation (483) is issued.
Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1043.60 |
| Cipla | 1047.05 |
| Dr. Reddys Lab | 4318.30 |
| Lupin | 742.20 |
| Zydus Lifesciences | 430.25 |
| View more.. | |
